
Sabinsa announces five new patents pertaining to digestive health, sports nutrition, heart health, and sexual health.

Sabinsa announces five new patents pertaining to digestive health, sports nutrition, heart health, and sexual health.

The two new consumer product applications under Friesland's Biotis Brain Health Benefit Solutions range are built on galacto-oligosaccharide, a dairy prebiotic shown to stimulate the growth of gut bacteria that could help consumers feel less stressed and anxious.

Advances in microbiome-based data science and technology—including AI-based analytics and the mainstream accessibility of powerful computer processing—will play a key role as next-generation food producers look to accelerate our understanding of nutrition and health.

Ganeden BC30, a patented spore-forming probiotic ingredient from Kerry, supports protein amino acid absorption, according to a recent clinical study.

Nutralliance announced that the line of 11 lactic acid-producing probiotic species manufactured by Ildong Biosciences is now self-affirmed GRAS.

A recent study found that supplementation with Bacillus subtilis DE111 from Deerland Probiotics and Enzymes modified the microbiome composition of children attending daycare.

Cargill has made a $25 million anchor investment in BioGaia, a leading probiotics manufacturing.

The new facility is scheduled to be operational in the summer of 2022 and will produce approximately 300 metric tons of HMOs per year.

DolCas Biotech Ltd. has added a highly concentrated all-natural ginger root extract called Ginfort to its portfolio of botanical ingredients.

In the United States, probiotics remain stuck in a murky regulatory environment, one that stifles innovation and market growth, and, at the end of the day, blocks potential health benefits for the consumer.

Cargill has made a significant investment in the Seventure Partners’ Health for Life Capital II fund, joining Danone, Novartis, and Lesaffre in a network of strategic investors.

A recent animal study found that supplementation with Lacidofil from Lallemand reduced anxiety-like behavior in rats with learned aversive association from infancy.

A new national survey commissioned by AbbVie found 72% of U.S. adults experience at least one gastrointestinal (GI) symptoms a few times a month or more. However, more than half (56%) of them have not told their doctor because they don’t think their GI symptoms require physician attention.

The goal is to aid retailers in ensuring that only the highest quality probiotics make it onto their shelves.

Health-conscious parents are demanding more from children’s nutrition products, driving manufacturers to innovate.

GanedenBC30, a spore-forming probiotic ingredient by Kerry, was approved by Brazilian regulatory agency, ANVISA, for the following health claim: “Bacillus coagulans GBI-30, 6086 can contribute to the health of the gastrointestinal tract.”

Ingredients by Nature is partnering with Israel-based Galam to distribute GOFOS, a short chain fructo-oligosaccharide.

A recent study found that supplementation with a spore-forming probiotic from Deerland Probiotics and Enzymes supports endothelial function and cholesterol.

Bio-K will expand Kerry’s current portfolio of probiotics.

Probiotics are no stranger to critics, but industry insiders describe why they expect this category to survive—and flourish.

The wellness industry faces a double-edged sword: its products have never been more popular, but production hurdles have never been higher.

Choosing the right active packaging solution for probiotics requires more than gut instinct.

A recent post-hoc analysis of a randomized clinical trial found that a probiotic formulation called Cerebiome increased brain-derived neurotrophic factor (BDNF) serum levels in subjects.

DuPont Nutrition and Biosciences, in collaboration with the Natural Marketing Institute recently surveyed U.S., Italian, and Chinese consumers to determine how attitudes have changed about probiotics since the COVID-19 outbreak.

Gnosis by Lesaffre has unveiled a new business strategy which is the continued focus on microorganisms and biotransformation processes such as fermentation to cultivate nutritional actives, probiotics, and yeasts that will target five key market segments.